Comparison of Low-Molecular-Weight Heparin and Warfarin for the Secondary Prevention of Venous Thromboembolism in Patients With Cancer

Guy Meyer, Zora Marjanovic, Judith Valcke, +7

Archives of Internal Medicine

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy.

Philippe Rougier, R. Bugat, Jean‐Yves Douillard, +19

Journal of Clinical Oncology

Phase I study of oxaliplatin in patients with advanced cancer

Jean Marc Extra, Marc Espié, Fabien Calvo, +3

Cancer Chemotherapy and Pharmacology

Advanced CancerMedicineCancer ManagementCancer TreatmentOncology +4

Phase I and pharmacokinetic study of Taxotere (RP 56976; NSC 628503) given as a short intravenous infusion.

Jean Marc Extra, Frédérique Rousseau, René Bruno, +3

PubMed

Chemoprevention StrategyPharmacokinetic StudyPharmacotherapyMetronomic ChemotherapyDermatology +19

Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trials

G G Chabot, D Abigerges, G. Catimel, +7

Annals of Oncology

Pharmacological StudyMedicineActive Metabolite Sn-38PharmacotherapyPopulation Pharmacokinetics +3

Phase I and pharmacokinetic study of the camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients.

M Forni, R. Bugat, G G Chabot, +6

PubMed

Pharmacokinetic StudyPathologyPharmacotherapyCancer PatientsMetronomic Chemotherapy +15

Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer

Jocelyne Jacquemier, Emmanuelle Charafe‐Jauffret, Florence Monville, +6

Breast Cancer Research

High dose-intensity of irinotecan administered every 3 weeks in advanced cancer patients: a feasibility study.

Yacine Merrouche, Jean Marc Extra, D Abigerges, +7

Journal of Clinical Oncology

Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?

Armelle Degeorges, Anne de Roquancourt, Jean Marc Extra, +5

Breast Cancer Research and Treatment

Breast OncologyMedicinePathologyBreast CancerCancer Treatment +4

A small GTP-binding protein is frequently overexpressed in peripheral blood mononuclear cells from patients with solid tumours

Stéphane Culine, Nicole Honoré, Violaine Closson, +5

European Journal of Cancer

Tumor BiologyG Protein-coupled ReceptorMedicineMalignant Blood DisorderImmunology +8